4McMillan R, Longmire R, Yelenosky R, et al. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura[J]. N Engl J Med, 1974,291(16) :812-817.
5Ben-Yehuda D, Gillis S, Eldor A. Clinical and therapeutic experience in 712 israeli patients with idiopathic thrombocytopenic purpura[J]. Acta Hemat, 1994,91 (1) : 1-6.
4[1]Mc Millam R Quantitation of Platelet Being IgG Produced in Vitro by Spleen from Patients with ITP[J]. North Eagl J Med, 1974,291: 812.
5[3]Ben D, Gillis S, Eldor A. Clinical and Therapeutic Experience in 712 Israeli Patients with ITP[J]. Acta Hemat,1994,91(1) :1.
6[4]Schwatz SI. Role of Splenectomy in Hematologic Disorders[J]. World J Surg, 1996,20(9): 1156.
7[5]Seufert RM. Surgery of the Spleen[M]. New York:Thieme Inc, 1986.62.
8[7]Nejean Y,Dufour V,Rain JD, et al. The Site of Platelet Destruction in Thrombocytopenic Purpura as a Predictive Index of the Efficacy of Splenectomy [ J ]. Br J Haemat,1991,79(2) :271.
2BALAGU E C,VELA S,TARGARONA E M,et al.Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura:study of clinical and laboratory data[J].Surg Endosc,2006,20(8):1208-1213.
3SHOJAIEFARD A,MOUSAVI S A,FEGHIHI S H,et al.Prediction of response to splenentomy in patients with idiopathetic thrombocytopenic purpura[J].World J Surg,2008,32(3):488-493.
4WANG J,WILEY J M,LUDDY R,et al.Chronic immune thrombocytopenic purpura in children:assessment of rituximab treatment[J].J Pediatr,2005,146(2):217-221.
5WATANABE Y,HORIUCHI A,YOSHIDA M,et al.Significance of laparoscopic splenectomy in patients with hypersplenism[J].World J Surg,2007,31(3):549-555.
